National Comprehensive Cancer Network



NCCN Oncology Research Program (ORP)
ORP Recent News
ORP Affiliate Research Consortium
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources

Prevention and Treatment of Cancer-Related Infections Guidelines Updated

The NCCN Clinical Practice Guidelines in Oncology™ for Prevention and Treatment of Cancer-Related Infections have been updated.

Updates include the addition of doripenim to the Antibacterial Agents Tables and tenofovir DF to the Antiviral Agents Tables. Updates regarding seasonal and pandemic strains of influenza, including H1N1, were also added.

A complete explanation of the updates is available by accessing the full Guidelines.